Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear receptor subfamily 1, group I, member 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | ecdysteroid receptor | nuclear receptor subfamily 1, group I, member 2 | 434 aa | 427 aa | 25.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | protein kinase shaggy | 0.0211 | 0.5094 | 0.5749 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0211 | 0.5094 | 0.5749 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0383 | 0.965 | 0.9498 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.5094 | 0.5094 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.025 | 0.6145 | 0.8672 |
Trypanosoma cruzi | Protein kinase B | 0.0268 | 0.6622 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0132 | 0.3028 | 0.3028 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0211 | 0.5094 | 0.5094 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0396 | 1 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.025 | 0.6145 | 0.8672 |
Echinococcus granulosus | nervana 2 | 0.025 | 0.6145 | 0.8672 |
Trichomonas vaginalis | AGC family protein kinase | 0.0132 | 0.3028 | 0.3028 |
Onchocerca volvulus | 0.0211 | 0.5094 | 0.5 | |
Entamoeba histolytica | protein kinase domain containing protein | 0.0211 | 0.5094 | 0.5094 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0255 | 0.6272 | 0.9026 |
Toxoplasma gondii | AGC kinase | 0.0383 | 0.965 | 1 |
Brugia malayi | intracellular kinase | 0.0211 | 0.5094 | 0.2963 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0211 | 0.5094 | 1 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0268 | 0.6622 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0211 | 0.5094 | 0.5094 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0211 | 0.5094 | 0.8122 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0211 | 0.5094 | 0.5749 |
Entamoeba histolytica | protein kinase, putative | 0.0132 | 0.3028 | 0.3028 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0268 | 0.6622 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0255 | 0.6272 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0268 | 0.6622 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0211 | 0.5094 | 0.5094 |
Entamoeba histolytica | protein kinase, putative | 0.0383 | 0.965 | 0.965 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0396 | 1 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0211 | 0.5094 | 0.2963 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0268 | 0.6622 | 1 |
Echinococcus multilocularis | nervana 2 | 0.025 | 0.6145 | 0.8672 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0255 | 0.6272 | 0.9026 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0211 | 0.5094 | 0.8122 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0268 | 0.6622 | 1 |
Entamoeba histolytica | protein kinase 2, putative | 0.0255 | 0.6272 | 0.6272 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0211 | 0.5094 | 0.5749 |
Entamoeba histolytica | protein kinase, putative | 0.0396 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0268 | 0.6622 | 0.6622 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0255 | 0.6272 | 1 |
Trichomonas vaginalis | serine/threonine-protein kinase sgk, putative | 0.0128 | 0.2901 | 0.2901 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0255 | 0.6272 | 0.9026 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0211 | 0.5094 | 0.5279 |
Trichomonas vaginalis | AGC family protein kinase | 0.0132 | 0.3028 | 0.3028 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0211 | 0.5094 | 0.7693 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.025 | 0.6145 | 0.8672 |
Entamoeba histolytica | protein kinase, putative | 0.0396 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0146 | 0.3378 | 0.3378 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.025 | 0.6145 | 0.8672 |
Echinococcus multilocularis | nervana 2 | 0.025 | 0.6145 | 0.8672 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0255 | 0.6272 | 0.9472 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0383 | 0.965 | 0.9498 |
Trichomonas vaginalis | AGC family protein kinase | 0.0396 | 1 | 1 |
Echinococcus granulosus | nervana 2 | 0.025 | 0.6145 | 0.8672 |
Giardia lamblia | Kinase, AGC PKA | 0.0255 | 0.6272 | 1 |
Echinococcus multilocularis | protein kinase shaggy | 0.0211 | 0.5094 | 0.5749 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0211 | 0.5094 | 0.5094 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0211 | 0.5094 | 0.2963 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0268 | 0.6622 | 0.6622 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 49 nM | Agonist activity at human pregnane X receptor expressed in HGPXR reporter cells | ChEMBL. | 18304819 |
EC50 (binding) | = 809 nM | Protection of human pregnane X receptor against proteolytic digestion in presence of trypsin | ChEMBL. | 18304819 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.